Contraceptive vaginal ring (NuvaRing) is a new combined hormonal contraceptive method.Each ring contains 2.7mg ethinyl estradiol (EE) and 11.7mg etonogestrel.The ring is characteristic with its ease of use,lower EE systemic exposure and excellent cycle control.Studies have demonstrated that the efficacy and safety of the ring are equivalent to combined oral contraceptive (COC).The side effects of the ring are fewer and the biocompatibility is good.Recent studies have proved that the NuvaRing is a new,effective hormonal contraceptive option for women.
来源：生殖医学杂志 2011 年 20卷 z2期
